Perfusion: Final Exam Flashcards

1
Q

Define Hypertension.

A

Hypertention= High Blood Pressure
Hypertension represents an elevation in the systolic and diastolic blood pressure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Blood Pressure calculation.

A

Blood Pressure (BP)= Cardiac Output (CO) x Systemic Vascular Resistance (SVR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cardiac Output calculation.

A

Cardiac Output (CO) = Stroke Volume (SV) x Heart Rate (HR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Systemic Vascular Resistance calculation.

A

Systemic Vascular Resistance= Dilated artery/vessel (Low resistance), A narrow and constricted artery/vessel (High resistance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Mean Arterial Blood pressure calculation.

A

MAP= 2(Diastolic) + sysolic
—————————–
3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are Beta-adrenergic Blockers?

A

Beta-blockers decrease heart rate and cardiac output by inhibiting the binding of epinephrine onto the beta receptors found on the myocardial fibres. Reducing the number of times the heart contracts and the force it contracts; causing the blood pressure to lower.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Where are Beta-1 Receptors Found?

A

Beta-1 receptors are predominantly found in three locations: the heart, the kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where are Beta-2 Receptors Found?

A

Beta-2 receptors are found in the bronchioles of the lungs, GI system, skeletal muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What do Beta-Blocker medications end in?

A

Beta-blocker medications end in ‘lol’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are ACE inhibitors?

A

Angiotensin-converting enzyme inhibitor medications inhibit the conversion of angiotensin I to angiotensin II. The decrease of angiotensin II reduces its vasoconstriction effects, therefore reducing the SVR resulting in vessel dilation. Ultimately, reducing blood pressure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Process of Angiotensinogen II Release.

A
  1. The blood pressure drops (Detected by the baroreceptors)
  2. The sympathetic nervous system is stimulated and sends signals to the kidneys
  3. Once stimulated the juxtaglomerular cells to release renin
  4. When angiotensinogen and renin combine they react together and transform into angiotensin I
  5. ACE (angiotensin-converting enzyme) is released from the endothelium of the kidneys. The purpose of the ACE enzyme is to convert Angiotensin I to Angiotensin II
  6. Angiotensin II is responsible for constricting the blood vessels and increasing blood volume
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What Are Calcium Channel Blockers?

A

Inhibit the movement of calcium into cardiac and vascular smooth muscle. They have a direct myocardial effect that reduces the cardiac output through a decrease in cardiac contractility and heart rate. They also act on the vascular and arterial smooth muscles causing relaxation and dilation of the blood vessels. Further contributing to the drop in blood pressure!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What do Calcium Channel Blockers End In?

A

Calcium channel blockers end in pene.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do Calcium Channel Blockers Work?

A

In order for the heart to contract the calcium must enter the cardiac muscle. Inhibiting the entrance of calcium inhibits cardiac contraction. Calcium channel blockers also work on the smooth muscles, causing arterial dilation!

  • They promote smooth muscle relaxation
  • Vasodilation
  • Decrease contractility of the heart
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are Diuretics?

A

Decrease circulation blood volume by helping to rid the body of salt (sodium) and water. The sodium helps remove water from your blood, decreasing the amount of fluid flowing through your veins and arteries. This reduces blood pressure.

  1. First Line of Treatment
  2. Increased Urine Output
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Loop Diuretics.

A

Blocks the re-absorption of Na+, K+, and Cl- at the loop of Henle. By blocking the reabsorption of sodium, chloride and potassium, they will excrete themselves with the waste and be removed from urine. As sodium exits the system, water will follow resulting in a decrease in blood volume, due to the increased loss of fluids.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Loop Diuretic Medications.

A

Furosemide (Lasix)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Thiazide Diuretics.

A

Work similarly to loop diuretics however block the re-absorption of Na+, K+, Cl- at the renal distal convoluted tubules. The loss of fluids will decrease the blood volume.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Thiazide Diuretic Medications.

A

Hydrochlorothiazide (HZTZ), Chlorothiazide (Diruil), Metolazone (Zaroxolyn)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Potassium Paring Diuretics.

A

Increase nephron reabsorption of potassium by interrupting sodium reabsorption in the collecting duct. Potassium-sparing diuretics block renal aldosterone, which increases sodium excretion but spares potassium.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Potassium Sparing Diuretic Medications.

A

Meds: Spironolactone (Aldactone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Osmotic Diuretics.

A

Inhibits reabsorption of water and sodium. They pull the solvent (water) into circulation and into the renal tubules at the proximal tubule and loop of Henle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Osmotic Diuretic Medications.

A

Meds: Mannitol (Osmitrol) and Isosorbide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Angiotensin II Receptor Blockers (ARBs).

A

ARBs inhibit the binding of angiotensin onto the receptors site of the smooth muscle cells. By antagonizing the receptor site, angiotensin is unable to bind and constrict the blood vessel.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

ARB’s Medications.

A

Meds: Losartan (Cozaar), Ibesartan (Avapro)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Adrenergic Antagonists.

A

Adrenergic antagonists are compounds that inhibit the action of adrenaline (epinephrine), noradrenaline (norepinephrine), and other catecholamines that control the autonomic outflow. By inhibiting the binding of catecholamines t the adrenergic receptor site these drugs play an antagonistic role which results in;

  • Decreased HR
  • Decreased Conduction rate
  • Decresed streghth of contratility
  • Vasodilation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Adrenergic Antagonist Medications.

A

Meds: Atenolol, Propranolol and Metoprolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Alpha1 Receptors.

A

Adrenergic receptors are located on the smooth muscles of the vascular, genitourinary, intestinal, and cardiac systems. When these receptors are stimulated they cause:

  • Vasoconstriction
  • Increase Heart Rate
  • Increase Blood Pressure
  • Pupil Dilation
  • Constriction of the urinary sphincter
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Alpha2 Receptors.

A

Alpha 2 receptors are found both in the brain and in the periphery. In the brain stem, they modulate sympathetic outflow. When stipulated they promote:

  • Increases releases of Epinephrine
  • Inhibits release of norepinephrine
  • Inhibits acetylcholine release
  • Vasoconstriction of arteries
  • Vasoconstriction of veins
  • Decreased GI motility
  • Decreased smooth muscle motility
30
Q

Beta1 Receptors.

A

Located on the myocardial muscle, when stimulated increases the myocardial activity and increases heart rate.

31
Q

Beta2 Receptors.

A

Located on the smooth muscles in the blood vessels, bronchi and in peripheries

Stimulation leads ro vasodilation and bronchodilation!

32
Q

What are lipoproteins?

A

Lipoproteins consist of cholesterol, triglycerides and phospholipids along with a protein carrier (apoprotein)

33
Q

What are the Two Types of Lipoproteins?

A
  1. High-Density Lipoproteins (HDL): made in the liver and small intestine and transports the cholesterol AWAY from the arteries and brought back to the liver, where it is then broken down with bile and excreted through feces.
  2. Low-Density Lipoproteins (LDL): transports cholesterol from the liver towards the tissues and arteries, where it is stored. The storage of cholesterol within the blood vessels contributes to the development of plaque and leads to atherosclerosis.
34
Q

Define Dyslipidemia.

A

Elevated total LDL levels (LDL= Bad Cholesterol) low levels of HDL

  • DYSLIPEDEMIA refers to the abnormal (excessive) amount of lipoproteins in the body.
35
Q

How is Cholesterol Synthesized?

A

Cholesterol is manufactured in the liver by a series of enzymatic reactions! Beginning with acetyl CoA is produced from the breakdown of fatty acids

  1. Acetyl CoA and acetoacetyl CoA initiate HMG-CoA synthase
  2. The HMG-CoA is synthesized (3-hydroxy-3methyl-glutaryl-CoA=HMG-CoA)
  3. The HMG-CoA reductase is synthesized and creates mevalonic acid
  4. Which Ultimately creates Cholesterol
36
Q

Signs and Symptoms of Dyslipidemia.

A
  • Chest Pain
  • Dizziness
  • Heart palpitations
  • Exhaustion
  • Swelling of ankles and feet
37
Q

How is Dyslipidemia Diagnosed?

A

By measuring serum lipid levels

38
Q

How is Dyslipidemia Treated?

A

Statins

39
Q

How do Statins Work?

A

Statins act by inhibiting HMG-CoA reductase, which results in a reduction of cholesterol synthesis. As the liver makes less cholesterol, it responds by making more LDL receptors on the surface of the liver cells

The more LDL receptors sites on the liver will increase the REMOVAL of LDL from the blood

Blood levels of BOTH cholesterol and LDL will be reduced

40
Q

Define Coronary Artery Disease.

A

Coronary artery disease is caused by plaque buildup in the wall of the arteries that supply blood to the heart

41
Q

What is Chronic CAD?

A

Chronic: narrowing of arteries over time, resulting in a fibrous/thick layer of plaque within the arterial wall. The thick layer is surrounding a small lipid pool but preserves the lumen.

Stable angina is a prominent symptom of chronic artery disease

Stable angina is identified through the onset of chest pain with exertion, and relief of pain when relaxed or after the administration of Nitroglycerin

42
Q

How much Nitroglycerine is Administered?

A

3 Tablets, 5 Minutes Apart

43
Q

What is Acute CAD?

A

Acute: suddenly reduced blood supply to the heart. This occurs when there is a large lipid pool within a coronary artery that is coated in a thin fibrous layer(unstable plaque). Causing a rupture of the plaque and initiating an inflammatory response, which will result in complete blockage of the artery!

Unstable angina is a common result. Unstable angina occurs when the heart doesn’t get enough blood flow and oxygen. Unstable angina is identified through the immediate onset of severe chest pain which is not relieved by nitroglycerin or relaxation.

44
Q

Define Hemostasis.

A

Hemostasis is the mechanism that leads to the cessation of bleeding from a blood vessel. This occurs in three steps; vascular spasm, platelet plug formation, and blood clot formation.

45
Q

Treatment for CAD.

A
  • Vasodilate! (administration of nitroglycerine)
    • 3 tabs, 5 minutes apart
  • Oxygenate (administer O2)
  • Treat the Obstruction
  • Treat the clotting
    • Three Drug Classes to treat clotting: Antiplatelets, Anticoagulants, Thrombolytics
46
Q

Antiplatelets.

A

These medications stop platelets from sticking together and forming a clot. Stopping the binding/linkage of platelets will inhibit the creation of a ‘plug’ in the injured area and inhibit the creation of a clot!

47
Q

Anticoagulants.

A

Inhibits parts of the coagulation cascade.

48
Q

How Does Unfractionated Heparin Work?

A

Unfractionated Heparin (UFH): These include heparin, UFH binds to antithrombin and enhances its ability to inhibit clotting factor – factor Xa. UFH doesn’t break down clots, but it keeps them from growing and stops new ones from forming.

  • Factor Xa is a serine protease that cleaves prothrombin to generate thrombin (no thrombin, no fibrin)
49
Q

How Does Low Molecular Weight Heparin Work?

A

Low Molecular weight heparin is administered AT HOME (not through IV) and has a different composition and is less potent with fewer side effects

50
Q

LMWH (low molecular weight heparin) Medications.

A

Enoxaparin, Dalteparin, Tinzaparin and Nadroparin

51
Q

Vitamin K Dependent Antagonists.

A

Act as antagonists to vitamin K (prothrombin which is produced in the liver and is vitamin K dependent!). Therefore; if prothrombin is unable to be synthesized, there is no transformation into thrombin and consequently the fibrinogen is unable to be spliced into fibrin! (No clot formation)

52
Q

Direct Thrombin Inhibitors.

A

These inhibit the cleavage of fibrinogen to fibrin by thrombin. (No Fibrin, no clot formation)

Meds: Bivalirudin, argatroban, and dabigatran(Prodrug).

53
Q

Define Thrombolytics.

A

Thrombolytic drugs dissolve blood clots by activating plasminogen, which forms a cleaved product called plasmin. Plasmin is a proteolytic enzyme that is capable of breaking cross-links between fibrin molecules, which provide the structural integrity of blood clots (By breaking down fibrin, we break down the structural mesh that the platelets are linked to).

54
Q

Define Heart Failure.

A

Heart failure is a chronic, progressive condition in which the heart muscle is unable to pump enough blood to meet the body’s needs for blood and oxygen. Basically, the heart can’t keep up with its workload.

55
Q

What are Phosphodiesterase Inhibitors?

A

Phosphodiesterase inhibitors prevent the phosphodiesterase enzymes from breaking down cAMP and cGMP in the cell. As a result, they increase the cAMP and cGMP, leading to a decrease in intracellular calcium, which causes vasodilation and smooth muscle relaxation.

  • The production of cAMP and cGMP are regulated by a molecule called nitric oxide, and their function is to help regulate physiological processes by decreasing the levels of calcium in the cell. Ultimately, cAMP and cGMP are broken down by phosphodiesterase enzymes. Therefore, the lack of phosphodiesterase leads to the inhibition of cAMP breakdown.
56
Q

Why are Phosphodiesterase Inhibitors Used in Heart Failure?

A

Promote blood vessel dilation (vasodilation) and smooth muscle relaxation as well as decrease the influx of calcium into the cells, overall reducing the workload on the heart.

57
Q

Define Dysrhythmia.

A

Cardiac dysrhythmias are a problem with the rate or rhythm of your heartbeat caused by changes in your heart’s normal sequence of electrical impulses. Dysrhythmia is a disturbance of a normal rhythm.

58
Q

Name the Three Types of Arrhythmias.

A
  1. Sinus Rhythms
  2. Atrial Rhythms
  3. Ventricular Rhythms
59
Q

What are the Two Types of Sinus Rhythms?

A

Sinus Bradycardia: When the SA node fires less than 60bpm (resulting in a slower HR)

Sinus Tachycardia: When the SA node fire more than 100bpm (resulting ina faster HR)

60
Q

Define Atrial Flutter.

A

caused by an electrical impulse that travels around in a localized self-perpetuation loop in the right atrium. This causes the atrial rate to be higher than the ventricular rate. It occurs when a short circuit in the heart causes the upper chambers (atria) to pump very rapidly.

61
Q

Define Atrial Fibrillation.

A

Caused by multiple electrical impulses that are initiated randomly. These un-synchronized, chaotic electrical signals cause the atria to quiver or fibrillate rather than contract.

62
Q

AV Nodal Re-entry Tachycardia.

A

Occurs when one or more extra electrical pathways near the Atrioventricular or AV node allow an electrical impulse to loop back on itself or short circuit. The episodes are due to an extra pathway located in or near the AV node that causes the heart to beat prematurely.

63
Q

Ventricular Tachycardia.

A

Caused by a single strong firing site or circuit in one of the ventricles.

Impulses starting in the ventricles produce ventricular premature beats that are regular and fast, ranging from 100 to 250 beats per minute.

64
Q

Define Ventricular Fibrillation.

A

Is caused by multiple weak ectopic sites in the ventricles. These un-synchronized, chaotic electrical signals cause the ventricles to quiver or fibrillate rather than contract. The heart pumps little or no blood.

65
Q

What is the First Line of Treatment for Ventricular fibrillation?

A
66
Q

Treatments for Arrhythmias (Medications).

A

Digoxin, Lidocaine, Amiodarone and surgical Implants

67
Q

Digoxin Mechanism of Action.

A

Digoxin has effects on the AV node. By stimulating the parasympathetic nervous system, it slows electrical conduction in the atrioventricular node, therefore, decreasing the heart rate

  • Decrease SA-AV node conduction= decrease in HR
68
Q

Lidocaine Mechanism of Action.

A

Lidocaine blocks cardiac sodium channels shortening the action potential. By blocking the influx of sodium ions into the membrane surrounding nerves. This prevents the initiation and conduction of impulses.

69
Q

Amiodarone Mechanism of Action.

A

relax smooth muscles that line vascular walls, and decrease peripheral vascular resistance (afterload). It blocks potassium channels, however, it also blocks sodium and calcium channels and is a beta-adrenoceptor blocker, allowing it to slow down the conduction of impulses.

70
Q
A